Advanced Filters
noise

Biejing, China Clinical Trials

A listing of Biejing, China clinical trials actively recruiting patients volunteers.

Found 2,316 clinical trials
C Chunrong Wang, MD

Development and Validation of Models to Predict Postoperative Complications for Patients With Cardiac Surgery

Patients undergoing cardiac surgery is routinely performed in clinical scenarios, highly postoperative morbidities and long-term mortality should be modified. A simple risk prediction model incorporating risk factors can help guide clinical decision making, patient counseling and treatment planning.

18 years of age All Phase N/A

Prospective Registry of the Current Status of Care for Patients With Coronary Artery Disease

The study will estimate the current status of care for participants with coronary artery disease

18 years of age All Phase N/A
Y Yuan Wang, PhD

A Registry Study of Biomarkers in Ischemic Heart Disease ( BIOMS-IHD )

The registry study aims to discover biomarkers for accurate classification and risk assessment of ischemic heart disease.

18 - 80 years of age All Phase N/A
L Lei Li, M.D.

ctDNA Methylation for Detecting Ovarian Cancer

Ovarian cancer is one of the most dangerous and leading gynecological cancer, with significant cancer-related mortality among women. However, current detection methods are still limited, with approximately 70% of patients with high-grade serous ovarian cancer often being advanced at the initial diagnosis and more than 80% with intraperitoneal spread. The …

18 years of age Female Phase N/A

The Overall Survival of Patients With Unresectable HCC in Real-life

Liver cancer is the fifth most common cancer and the second most frequent cause of cancer-related death globally. Hepatocellular carcinoma represents about 90% of primary liver cancers and constitutes a major global health problem. The pattern of HCC occurrence shows a significant geographical imbalance, with the highest incidence rates in …

18 years of age All Phase N/A

The China National COPD Screening Program

The national COPD screening program is in a cross-sectional manner at the baseline, planning to recruit a total of 800,000 participants from 160 districts or counties (5,000 for each site on average) from 31 provinces, autonomous regions or municipalities directly under the central government of China. The filtered COPD high-risk …

35 - 75 years of age All Phase N/A
F Fu-Dong Shi

China National Registry of Neuro-Inflammatory Diseases

Central nervous system (CNS) idiopathic inflammatory demyelinating diseases (IDD) are mainly diseases caused by autoimmune factors that result in CNS demyelination damage and loss. It tends to accumulate in the brain, spinal cord and optic nerves. Multiple sclerosis (MS), clinically isolated syndrome (CIS), neuromyelitis optica spectrum disorder (NMOSD), myelin oligodendrocyte …

years of age All Phase N/A
Z Zhichao Lai, MD

Optimization Strategy of Carotid Artery Stenosis

The goal of this observational study is to learn about how to utilize multiple evaluation techniques in carotid artery stenosis patients for optimizing assessment of diagnosis and treatment strategy. The main questions it aims to answer are: Identify best strategy that use multi-modal MRI and CT to assess patients' cerebral …

18 years of age All Phase N/A

China Health Big Data

In this nationwide multi center study the investigators combine the low dose chest CT scan data with QCT technology, to measure the BMD of spine, VAT and liver fat in the health check subjects. The aim of this study is to evaluate the performance of QCT in the health check …

30 - 90 years of age All Phase N/A

Chronic Kidney Disease Registry Platform Study

This is a multicenter, prospective, observational registry platform study which is designed to establish a CKD registry platform by collecting data on the demographics, etiology and staging, clinical characteristics, diagnostic and treatment patterns, and clinical outcomes of patients with chronic kidney disease (CKD), to describe the current status of the …

18 years of age All Phase N/A

Simplify language using AI